trial · primary record
CliniMACS CD34 Reagent
Myeloid Chimerism
| Phase | Phase 1, Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 32 |
| Primary completion | 2037-12-01 |
| Primary endpoint | dichotomous positive/negative outcome where a positive response is defined by absence of graft rejection |
| Registry ID | NCT04008368 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:31:56.864Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT04008368
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.